跳至主要内容
临床试验/NCT04237597
NCT04237597已完成1 期

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Kowa Research Institute, Inc.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Area under the plasma concentration versus time curve (AUC)

研究概览

简要总结

A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Subject provides written informed consent before any study-specific evaluation is performed.
  • Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive, at Screening.
  • Subject has a BMI of 18 to 30 kg/m2, inclusive, at Screening.
  • Subject meets all other inclusion criteria outlined in the clinical study protocol

排除标准

  • Subject has clinically relevant abnormalities at Screening or at Check-in assessments.
  • Subject is pregnant or breastfeeding or intends to become pregnant within 30 days after the last dose of study drug.
  • Subject does not meet any other exclusion criteria outlined in the clinical study protocol.

研究组 & 干预措施

K-877 & CSG452

Experimental

K-877 Single dose on Day 1 and Day 15 CSG452 Repeat dose on Day 2 Through Day 15

干预措施: K-877 (Drug)

K-877 & CSG452

Experimental

K-877 Single dose on Day 1 and Day 15 CSG452 Repeat dose on Day 2 Through Day 15

干预措施: CSG452 (Drug)

结局指标

主要结局

Area under the plasma concentration versus time curve (AUC)

时间窗: 0 to 24 hours

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pharmacokinetic Drug-Drug Interaction Study Between... | 临床试验